Difference between revisions of "Avatrombopag (Doptelet)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "Category:Immune thrombocytopenia (ITP) medications" to "Category:Immune thrombocytopenia medications") |
||
| Line 19: | Line 19: | ||
[[Category:Megakaryocyte growth factors]] | [[Category:Megakaryocyte growth factors]] | ||
| − | [[Category:Immune thrombocytopenia | + | [[Category:Immune thrombocytopenia medications]] |
[[Category:Thrombocytopenia in liver disease medications]] | [[Category:Thrombocytopenia in liver disease medications]] | ||
[[Category:FDA approved in 2018]] | [[Category:FDA approved in 2018]] | ||
Revision as of 19:17, 27 February 2019
Mechanism of action
Thrombopoietin receptor agonist
Diseases for which it is used
History of changes in FDA indication
- 5/21/2018: FDA approved for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
Also known as
- Code names: E5501, YM477, AKR 501
- Brand name: Doptelet